NBIX Neurocrine Biosciences Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
01:26
Apr 07
BarbarianCap Twitter Analyst
Neurocrine's acquisition of Soleno adds a promising late-stage asset, providing strategic long-term growth for NBIX.
NBIX 1ST
MED

About NBIX Analyst Coverage

Buzzberg tracks NBIX (Neurocrine Biosciences) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Latest voices: BarbarianCap.